Stock Analiz

Climb Bio, Inc. (CLYM) stock forecast and price target

Price $10.36 · data as of November 13, 2026

12-month price target

Average target$28.40
Upside / downside+174.1%
Analysts15
ConsensusStrong buy
Low $18.00Average $28.40High $40.00

Gold marker: average target · white marker: today’s price ($10.36)

Analyst ratings

Strong buy 2Buy 14Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.75+14.8%$0
Next fiscal year
ends December 31, 2027
$-0.99−32.5%$500000
Next quarter
ends December 31, 2026
$-0.19+26.1%$0
Quarter after
ends March 31, 2027
$-0.23−13.0%$0

Consensus of the analysts covering Climb Bio, updated daily. In the last 30 days 3 estimates were raised and 2 lowered.

Frequently asked questions

What is the Climb Bio stock price target?

The average 12-month target from 15 analysts is $28.40, 174.1% above the current price of $10.36 Targets range from $18.00 to $40.00.

Is Climb Bio a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 14 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Climb Bio expected to earn?

Analysts expect EPS of $-0.75 for the fiscal year ending December 31, 2026 and $-0.99 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.